Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.91 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL31533366 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL101303 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL31314243 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL30991839 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL2771868 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL9133500 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL31316366 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Tartaric Acid SCHEMBL31289378 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Cadaverine Tartrate SCHEMBL7776179 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A | |
| Tartaric Acid SCHEMBL29494971 | 1.00 | TSHR (0.91) | TSHROR51E2TP53CYP2C9PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250366505-A1 | AEROSOL-GENERATING SUBSTRATES AND ENCAPSULATED FLAVORANTS | ALTRIA CLIENT SERVICES LLC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250339380-A1 | ENCAPSULATED NICOTINE GRANULES AND METHODS OF PREPARATION THEREOF | ALTRIA CLIENT SERVICES LLC (US) | 2025-11-06 | — | — | US | claimed |
| CN-119100726-A | High freeze-thawing resistant concrete pavement quick repairing agent | 拓达(山东)新材料科技产业集团有限公司 | 2024-12-10 | — | — | CN | claimed |
| US-20240183779-A1 | METHOD FOR SENSING METHYL SALICYLATE, METHYL SALICYLATE SENSOR, AND METHOD FOR DETECTING PATHOGEN INFECTION OF PLANTS | NEC CORPORATION (JP) | 2024-06-06 | — | — | US | claimed |
| CN-118084432-A | Quick-setting concrete ground repair material | 抚顺市抚耐高新材料厂 | 2024-05-28 | — | — | CN | claimed |
| EP-4319572-A1 | ENCAPSULATED NICOTINE GRANULES AND METHODS OF PREPARATION THEREOF | Altria Client Services LLC (US) | 2024-02-14 | — | — | EP | claimed |
| EP-4319573-A1 | SPRAY DRIED NICOTINE FOR INCLUSION IN ORAL PRODUCTS | Altria Client Services LLC (US) | 2024-02-14 | — | — | EP | claimed |
| WO-2022216323-A1 | SPRAY DRIED NICOTINE FOR INCLUSION IN ORAL PRODUCTS | ALTRIA CLIENT SERVICES LLC (US) | 2022-10-13 | — | — | WO | claimed |
| WO-2022216324-A1 | ENCAPSULATED NICOTINE GRANULES AND METHODS OF PREPARATION THEREOF | ALTRIA CLIENT SERVICES LLC (US) | 2022-10-13 | — | — | WO | claimed |
| US-20220313678-A1 | SPRAY DRIED NICOTINE FOR INCLUSION IN ORAL PRODUCTS | ALTRIA CLIENT SERVICES LLC (US) | 2022-10-06 | — | — | US | claimed |
| US-20220313614-A1 | ENCAPSULATED NICOTINE GRANULES AND METHODS OF PREPARATION THEREOF | ALTRIA CLIENT SERVICES LLC (US) | 2022-10-06 | — | — | US | claimed |
| EP-4018846-A1 | A POUCHED PRODUCT FOR ORAL USE COMPRISING A LIQUID PERMEABLE COVER MATERIAL AND A FILLING MATERIAL COMPRISING A FIRST TYPE OF PARTICLES | Swedish Match North Europe AB (SE) | 2022-06-29 | — | — | EP | claimed |
| CN-106928218-A | Salt and crystal form of morpholine derivative, preparation method, pharmaceutical composition and application thereof | 上海医药集团股份有限公司 | 2017-07-07 | — | — | CN | claimed |
| JP-2011501765-A | — | — | 2011-01-13 | — | — | JP | claimed |
| EP-2195380-A2 | IN-SITU METHODS OF GENERATING WATER THROUGH THE DEHYDRATION OF METAL SALT HYDRATES FOR MOISTURE CROSSLINKING OF POLYOLEFINS | Dow Global Technologies Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| WO-2009045744-A2 | IN-SITU METHODS OF GENERATING WATER THROUGH THE DEHYDRATION OF METAL SALT HYDRATES FOR MOISTURE CROSSLINKING OF POLYOLEFINS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-04-09 | — | — | WO | claimed |
| CN-1703145-A | Fast dissolving solid ortho-phthalic aldehyde formulations | DOW GLOBAL TECHNOLOGIES INC (US) | 2005-11-30 | — | — | CN | claimed |
| EP-4319563-B1 | CONTROLLED-RELEASE NICOTINE CHEWING GUM | ALTRIA CLIENT SERVICES LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-3998878-A | PRECIPITATION WITH CALCIUM ION AT CONTROLLED PH | BOISE CASCADE CORPORATION (US) | 1976-12-21 | — | — | US | disclosed |
| US-3956336-A | NARCOTIC ANTAGONIST, ANALGESICS | BRISTOL-MYERS COMPANY (US) | 1976-05-11 | — | — | US | disclosed |